Watch our webinar outlining the next general central lab services that provide lab assessments, kits, logistics support, and delivery of data in certain formats. Frontage can provide lab testing on both medical diagnostics and clinical trial spaces.
Register to gain access to gated resources.
Thank you for registering!
You may now view the resource below.
Frontage’s Biologics, Gene, and Cell Therapy Operations (BGC) Unit supports the development of biologics products. We develop complex analytical techniques to support drug substances, drug products, comparability studies, and stability programs.
In this poster, we validate ultra-high sensitive SIMOA assays for the successful quantitation of neurofilament light chain (NF-L) and glial fibrillary acidic protein (GFAP).
Gene therapy holds the promise to transform medicine and creates options for patients who are living with incurable diseases. The industry has been booming in the last 20 years. Before a gene therapy product can be used in humans, the product must be tested for safety and effectiveness. This webinar focuses on the introduction of three critical test methods: AUC, Infectivity and RCL assays. Newly released FDA draft guidance for Industry on human gene therapy products will also be discussed.